Parasol Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Parasol Investment Management's BMY Position: Q1 2017 in Review
Parasol Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 97% in Q1 2017, selling an estimated $206K and leaving 100 shares worth $5K. The position accounts for 0.01% of the portfolio, ranked #89.
Parasol Investment Management first reported a position in BMY in Q2 2014 and has held it in 12 quarters since. The position peaked at $248K in Q2 2016. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.
- Parasol Investment Management held 100 shares of Bristol-Myers Squibb worth $5K as of Q1 2017.
- Parasol Investment Management sold 3,750 Bristol-Myers Squibb shares in Q1 2017, an estimated $206K.
- Bristol-Myers Squibb made up 0.01% of Parasol Investment Management's portfolio in Q1 2017, its #89 holding.
- Parasol Investment Management first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 12 quarters since.
- Parasol Investment Management's Bristol-Myers Squibb position peaked at $248K in Q2 2016.
- 1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.
Based on Parasol Investment Management's 13F filing for Q1 2017, filed 24 Apr 2017.